Mooney, M E <br/><br/>
Bupropion and naltrexone for smoking cessation: A double-blind randomized placebo-controlled clinical trial.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  10 2016 
 - 344-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1002/cpt.402  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antidepressive Agents, Second-Generation--adverse effects<br/>Bupropion--adverse effects<br/>Double-Blind Method<br/>Drug Therapy, Combination--adverse effects<br/>Female<br/>Humans<br/>Male<br/>Naltrexone--adverse effects<br/>Narcotic Antagonists--adverse effects<br/>Patient Compliance<br/>Smoking--drug therapy<br/>Smoking Cessation--methods<br/>Substance Withdrawal Syndrome--drug therapy<br/>Treatment Outcome<br/>Young Adult